Aeovian Pharmaceuticals

IAMA Therapeutics

This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.

Lario Therapeutics

This company develops precision medicines for patients with severe neurological disorders, including epilepsy and Parkinson’s disease.

Actio Biosciences

This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.

Axovia Therapeutics

The company develops gene therapies for patients with ciliopathies, specifically targeting rare genetic conditions like Bardet-Biedl Syndrome to treat blindness and obesity.

Apexian Pharmaceuticals

This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.

Augustine Therapeutics

This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.

Atavistik Bio

This biotechnology company develops oral allosteric small molecule therapeutics for patients with rare hematological diseases and cancers.